# High-amylose Barley (HIAMBA) in the Regulation and Prevention of Type 2 Diabetes

> **NCT04702672** · NA · COMPLETED · sponsor: **University of Aarhus** · enrollment: 38 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DIETARY_SUPPLEMENT:** 100% wheat (control)
- **DIETARY_SUPPLEMENT:** 100% Lean-baking barley®
- **DIETARY_SUPPLEMENT:** 100% regular barley

## Key facts

- **NCT ID:** NCT04702672
- **Lead sponsor:** University of Aarhus
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-01
- **Primary completion:** 2024-07-01
- **Final completion:** 2024-07-31
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2024-11-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04702672

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04702672, "High-amylose Barley (HIAMBA) in the Regulation and Prevention of Type 2 Diabetes". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04702672. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*